Regeners
Latest round
- Seed
Last raised
- Oct 2022
Total raised
- $1.2M
Investors
- 3
About Regeners
Founded in 2021, and based in Daejeon, South Korea, Regeners Inc. is a biotechnology company that conducts research and development of stem cell therapeutics using its proprietary direct reprogramming technology to develop cell regeneration medicine. The firm employs its proprietary PDR technology (Pluripotency factor-mediated Direct Reprogramming) that analyzes cells in the intermediate stages and induces direct cross-differentiation/development to create a variety of therapeutic cells. The generated cells can be used to reverse the aging in cells and also generate additional nerve cells, cardiomyocytes, liver cells, etc.
Who invested in Regeners
3 investors across 2 rounds
See all investors in Regeners
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Regeners
Who invested in Regeners?
Regeners has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Regeners raised?
Regeners has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Regeners last raise money?
Regeners's most recent round on record is a Seed, in Oct 2022.
What does Regeners do?
Founded in 2021, and based in Daejeon, South Korea, Regeners Inc.
Where is Regeners headquartered?
Regeners is headquartered in Daejeon, South Korea.
Which VCs invest in companies like Regeners?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Regeners's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Regeners? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.